Losing muscle along with fat is counterproductive and potentially dangerous, especially for older adults
Candidacy: Who Should Consider Each Peptide
If the GLP-1/GIP/glucagon receptor class shows disease-modifying behaviour in OA rather than just mechanical pain relief from weight loss, it expands the scientific rationale for the compound and reinforces the argument that the triple-agonist mechanism is doing more than suppressing appetite
The satiety factor is realcheese's protein and fat combination triggers hormones that signal fullness, potentially reducing overall calorie intake
Substituting sterile water for bacteriostatic water might seem like a viable option, but it's not always suitable
On September 19, 2025, the FDA issued Import Alert 66-80, which authorizes field staff to detain without physical examination shipments of GLP-1 active pharmaceutical ingredients (APIs) from manufacturers not included on its newly established Green List.[1] This action follows FDAs September 5 th announcement of the Green List initiative to curb illegal imports of semaglutide, tirzepatide, and other corresponding APIs.[2] Together, the Green List and Import Alert form FDAs most aggressive enforcement measures to date against GLP-1 imports
